Induction of matrix gla protein synthesis during prolonged 1,25-Dihydroxyvitamin D3 treatment of osteosarcoma cells

  • James D. Fraser
  • Paul A. Price
Molecular and Cellular Biology


The synthesis of matrix Gla protein (MGP) and bone Gla protein (BGP) have been shown to be mutually exclusive in all osteosarcoma cell lines investigated. In the cell lines that produce the respective proteins, synthesis is stimulated by 1,25-dihydroxyvitamin D3(1,25(OH)2D3) within the first several hours of hormone treatment. In the present studies we have investigated the effects of longer-term treatment with 1,25(OH)2D3 in the ROS 17/2 cell line, a cell line that synthesizes BGP constitutively but does not synthesize MGP. In agreement with earlier studies, the rate of BGP synthesis increases within 8 hours of hormone treatment, is maximal by 24 hours, and remains at the maximal rate through 48 hours of 1,25(OH)2D3 treatment. The present study is the first to report that the rate of BGP secretion at times beyond 48 hours declines to that of control cultures despite the continued administration of 1,25(OH)2D3, and that MGP synthesis is induced in ROS 17/2 cells by 48 hours of 1,25(OH)2D3 treatment. At this time, MGP mRNA could be detected by northern blot analysis and MGP secretion could be demonstrated by radioimmunoassay of culture medium. Both the level of MGP message per unit total RNA and the rate of MGP secretion into culture medium increased steadily between 2 and 6 days of 1,25(OH)2D3 treatment. The MGP synthesized by the 1,25(OH)2D3-treated ROS 17/2 cells was identical to that found in bone by northern blot analysis of message and by western blot analysis of the media antigen. Halfmaximal induction of MGP synthesis was obtained with 0.3 nM 1,25(OH)2D3, a 60-fold higher dosage than was required for the half maximal stimulation of BGP synthesis in these cells. Treatment of ROS 17/2 cells with 24,24-F21,25(OH)2D3 suggests that the observed difference in dose dependence is not due to an increased rate of hormone catabolism.

Key words

Matrix Gla protein Bone Gla protein Osteosarcoma cells 1,25(OH)2D3 ROS 17/2 cell line 


  1. 1.
    Hauschka PV, Lian JB, Gallop PM (1975) Direct identification of the calcium-binding amino acid, γ-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci USA 72:3925–3929PubMedCrossRefGoogle Scholar
  2. 2.
    Price PA, Otsuka AS, Poser JW, Kristaponis J, Raman N (1976) Characterization of a γ-carboxyglutamic acidcontaining protein from bone. Proc Natl Acad Sci USA 73:1447–1451PubMedCrossRefGoogle Scholar
  3. 3.
    Price PA, Urist MR, Otawara Y (1983) Matrix gla protein, a new γ-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Comm 117:765–771PubMedCrossRefGoogle Scholar
  4. 4.
    Price PA, Williamson MK (1985) Primary structure of bovine matrix gla protein, a new vitamin K-dependent bone protein. J Biol Chem 260:14971–14975PubMedGoogle Scholar
  5. 5.
    Poser JW, Price PA (1979) A method for decarboxylation of γ-carboxyglutamic acid in proteins. J Biol Chem 254:431–436PubMedGoogle Scholar
  6. 6.
    Otwara Y, Price PA (1986) Developmental apperance of matrix gla protein during calcification in the rat. J Biol Chem 261:10828–10832Google Scholar
  7. 7.
    Price PA, Williamson MK, Haba T, Dell RB, Jee WSS (1982) Excessive mineralization with growth plate closure in rats on chronic warfarin treatment. Proc Natl Acad Sci USA 79:7734–7738PubMedCrossRefGoogle Scholar
  8. 8.
    Nishimoto SK, Price PA (1980) Secretion of the vitamin K-dependent protein of bone by rat osteosarcoma cells. Evidence from an intracellular precursor. J Biol Chem 255:6579–6583PubMedGoogle Scholar
  9. 9.
    Fraser JD, Otawara Y, Price PA (1988) 1,25-Dihydroxyvitamin D3 stimulates the synthesis of matrix gla protein by osteosarcoma cells. J Biol Chem 263:911–916PubMedGoogle Scholar
  10. 10.
    Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T (1981) Differentiation of mouse myeloid leukemia cells induced by 1 alpha, 25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 78:4990–4994PubMedCrossRefGoogle Scholar
  11. 11.
    Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishi Y, Suda T (1982) 1 alpha, 25-dihydroxycholecalciferol and a human myeloid leukemia cell line (HL-60). Biochem J 204:713–719PubMedGoogle Scholar
  12. 12.
    Bar-Shavit Z, Teitelbaum SL, Reitsma P, Hall A, Pegg LE, Trial J, Kahn AJ (1983) Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 80:5907–5911PubMedCrossRefGoogle Scholar
  13. 13.
    Dodd RC, Cohen MS, Newman SL, Gray TK (1983) Vitamin D metabolites change the phenotype of monoblastic U937 cells. Proc Natl Acad Sci USA 80:7538–7541PubMedCrossRefGoogle Scholar
  14. 14.
    Mangelsdorf DJ, Koeffler HP, Donaldson CA, Pike WP, Haussler MR (1984) 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol 98:391–398PubMedCrossRefGoogle Scholar
  15. 15.
    Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T (1983) Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha, 25-dihydroxyvitamin D3. Endocrinology 113:1950–1957PubMedGoogle Scholar
  16. 16.
    MacLaughlin JA, Gange W, Taylor D, Smith E, Holick MF (1985) Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 82:5409–5412PubMedCrossRefGoogle Scholar
  17. 17.
    Majeska RJ, Rodan GA (1982) The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells. J Biol Chem 257:3362–3365PubMedGoogle Scholar
  18. 18.
    Dokoh S, Donaldson CA, Haussler MR (1984) Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor. Cancer Res 44:2103–2109PubMedGoogle Scholar
  19. 19.
    Majeska RJ, Rodan SB, Rodan GA (1980) Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology 107:1494–1503PubMedGoogle Scholar
  20. 20.
    Price PA, Nishimoto SK (1980) Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci USA 77:2234–2238PubMedCrossRefGoogle Scholar
  21. 21.
    Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685PubMedCrossRefGoogle Scholar
  22. 22.
    Towbin A, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354PubMedCrossRefGoogle Scholar
  23. 23.
    Chirgwin JM, Przbyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299PubMedCrossRefGoogle Scholar
  24. 24.
    Seed B (1982) Attachment of nucleic acids to nitrocellulose and diazonium-substituted supports. In: Setlow JK, Hollaender A (eds) Genetic engineering: Principles and methods, vol 4, Plenum Press, New York, p 91–102Google Scholar
  25. 25.
    Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, p 203–206Google Scholar
  26. 26.
    Pan LC, Price PA (1985) The propeptide of rat bone γ-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors. Proc Natl Acad Sci USA 82:6109–6113PubMedCrossRefGoogle Scholar
  27. 27.
    Price PA, Fraser JD, Metz-Virca G (1987) Molecular cloning of matrix gla protein: implications for substrate recognition by the vitamin K-dependent γ-carboxylase. Proc Natl Acad Sci USA 84:8335–8339PubMedCrossRefGoogle Scholar
  28. 28.
    Nudel U, Katcoff D, Zakut R, Shani M, Carmon Y, Finer M, Czosnek H, Ginsburg I, Yaffe D (1982) Isolation and characterization of rat skeletal muscle and cytoplasmic actin genes. Proc Natl Acad Sci USA 79:2763–2767PubMedCrossRefGoogle Scholar
  29. 29.
    Rigby PW, Dieckman M, Rhodes C, Berg P (1977) Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol 113:237–251PubMedCrossRefGoogle Scholar
  30. 30.
    Singh L, Jones KW (1984) The use of heparin as a simple cost-effective means of controlling background in nucleic acid hybridization procedures. Nucleic Acids Res 12:5627–5638PubMedCrossRefGoogle Scholar
  31. 31.
    Price PA, Baukol SA (1980) 1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J Biol Chem 255:11660–11663PubMedGoogle Scholar
  32. 32.
    Lohnes D, Jones G (1987) Side chain metabolism of vitamin D3 in osteosarcoma cell line UMR-106. Characterization of products. J Biol Chem 262:14394–14401PubMedGoogle Scholar
  33. 33.
    Tanaka Y, DeLuca HF, Schnoes HK, Ikekawa N, Kobayashi Y (1980) 24,24-difluoro-1,25-dihydroxyvitamin D3: in vitro production, isolation and biological activity. Arch Biochem Biophys 199:473–478PubMedCrossRefGoogle Scholar
  34. 34.
    Halloran BP, DeLuca HF, Barthell E, Yamada S, Ohmori M, Takayama H (1981) An examination of the importance of 24-hydroxylation to the function of vitamin D during early development. Endocrinology 108:2067–2071PubMedGoogle Scholar
  35. 35.
    Miller SC, Halloran BP, DeLuca HF, Yamada S, Takayama H, Jee WSS (1981) Studies on the role of 24-hydroxylation of vitamin D in the mineralization of cartilage and bone of vitamin D-deficient rats. Calcif Tissue Int 33:489–497PubMedCrossRefGoogle Scholar
  36. 36.
    Eisman JA, DeLuca HF (1977) Intestinal 1,25-dihydroxy-vitamin D3 binding protein: specificity of binding. Steroids 30:245–257PubMedCrossRefGoogle Scholar
  37. 37.
    Haussler MR (1986) Vitamin D receptors: nature and function. Ann Rev Nutr 6:527–562CrossRefGoogle Scholar
  38. 38.
    Costa EM, Hirst MA, Feldman D (1985) Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells. Endocrinology 117:2203–2210PubMedGoogle Scholar
  39. 39.
    Hirst M, Feldman D (1983) Regulation of 1,25(OH)2 vitamin D3 receptor content in cultured LLC-PK1 kidney cells limits hormonal responsiveness. Biochem Biophys Res Comm 116:121–127PubMedCrossRefGoogle Scholar
  40. 40.
    Sher E, Frampton RJ, Eisman JA (1985) Regulation of the 1,25-dihydroxyvitamin D3 receptor by 1,25-dihydroxyvitamin D3 in intact human cancer cells. Endocrinology 116:971–977PubMedCrossRefGoogle Scholar
  41. 41.
    Pan LC, Price PA (1987) Ligand-dependent regulation of the 1,25-dihydroxyvitamin D3 receptor in rat osteosarcoma cells. J Biol Chem 262:4670–4675PubMedGoogle Scholar
  42. 42.
    Thompson CC, Weinberger C, Lebo R, Evans RM (1987) Indentification of a novel thyroid hormone receptor expressed in the mammalian central nervous system. Science 237:1610–1614PubMedCrossRefGoogle Scholar
  43. 43.
    Pierce EA, Dame MC, DeLuca HF (1987) Size and charge of the functional 1,25-dihydroxyvitamin D receptor in procine intestine. J Biol Chem 262:17092–17099PubMedGoogle Scholar
  44. 44.
    Pike JW, Sleartor NM (1985) Hormone-dependent phosphorylation of the 1,25-dihydroxyvitamin D3 receptor in mouse fibroblasts. Biochem Biophys Res Commun 131:378–385PubMedCrossRefGoogle Scholar
  45. 45.
    Housley PR, Pratt WB (1983) Direct demonstrations of glucocorticoid receptor phosphorylation by intact L-cells. J Biol Chem 258:4630–4635PubMedGoogle Scholar
  46. 46.
    Dougherty JJ, Puri RK, Toft DO (1982) Phosphorylation in vivo of chicken oviduct progesterone receptor. J Biol Chem 257:14226–14230PubMedGoogle Scholar
  47. 47.
    Auricchio F, Migliaccio A, Castoria G, Lastoria S, Rotondi A (1982) Evidence that in vivo estradiol receptor translocated into nuclei is dephosphorylated and released into cytoplasm. Biochem Biophys Res Commun 106:149–157PubMedCrossRefGoogle Scholar
  48. 48.
    Smith RG, Clarke SG, Zalta E, Taylor RN (1979) Two estrogen receptors in reproductive tissue. J Steroid Biochem 10:31–35PubMedCrossRefGoogle Scholar
  49. 49.
    McNaught RW, Smith RG (1986) Characterization of a second estrogen receptor species in chick oviduct. Biochemistry 25:2073–2081PubMedCrossRefGoogle Scholar
  50. 50.
    McNaught RW, Raymoure WJ, Smith RG (1986) Receptor interconversion model of hormone action. I. ATP-mediated conversion of estrogen receptors from a high to lower affinity state and its relationship to antiestrogen action. J Biol Chem 261:17011–17017PubMedGoogle Scholar
  51. 51.
    Rodan GA, Rodan SB (1984) Expression of the osteoblastic phenotype. In: Peck WA (ed) Bone and mineral research annual 2. Elsevier, Amsterdam, p 244–285Google Scholar
  52. 52.
    Manolagas SC, Burton DW, Deftos LJ (1981) 1,25-dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem 256:7115–7117PubMedGoogle Scholar
  53. 53.
    Price PA, Sloper SA (1983) Concurrent warfarin treatment further reduces bone mineral levels in 1,25-dihydroxyvitamin D3-treated rats. J Biol Chem 258:6004–6007PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc 1990

Authors and Affiliations

  • James D. Fraser
    • 1
  • Paul A. Price
    • 1
  1. 1.Department of BiologyUniversity of California at San DiegoCaliforniaLa JollaUSA

Personalised recommendations